45% of clinical trials are conducted exclusively in non-U.S. countries, and only 6% are registered in both the U.S. and rest of world. The globalization of clinical trials demands deeper knowledge and greater efficiencies in planning and execution.
Dan McDonald, Director of Business Development at DAC Patient Recruitment Services, explores this issue in his interview with Susan Flint, Executive Director & Head of Clinical Operations at Oxyrane Pharmaceuticals.
Learn actionable solutions to real-world multinational clinical trial challenges, including:
Subscribe to the Imperial Family Blog for email alerts of new podcasts!